Mineola, New York 11501


Purpose:

This project aims to result in the identification of such markers, and the development of a feasible quantitative method of distinguishing between tissue that has the capacity to heal and tissue that does not, thus identifying a non-healing phenotype.


Study summary:

The goal of this project is to identify objective, quantitative biological and molecular markers that correlate with healing outcomes for diabetic foot ulcers (DFUs) using debrided tissue of patients with wounds. This project aims to result in the identification of such markers, and the development of a feasible quantitative method of distinguishing between tissue that has the capacity to heal and tissue that does not, thus identifying a non-healing phenotype. The ability to differentiate between healing and non-healing tissue at the onset of wound care will allow for the use of targeted therapies and earlier initiation of aggressive treatments where indicated.


Criteria:

Inclusion Criteria: - Male or female, age ≥ 18 - Type 2 Diabetes - A break in the skin on the foot ≥ 0.5cm2 and is Grade 1 or 2 as defined by the Wagner grading system - Hemoglobin A1c ≥ 5.9% - Ability to provide written informed consent Exclusion Criteria: - Any experimental drugs taken orally or topically within 4 weeks of study entry - Malignant disease at/or in proximity to the DFU - Target wound of malignant origin - Failure to satisfy at least one inclusion criterion for one of the two study groups.


NCT ID:

NCT02329366


Primary Contact:

Principal Investigator
Harold Brem, MD
Winthrop University Hospital

Julie DiGregorio, CCRP
Phone: (516) 663-9614
Email: jdigregorio@winthrop.org


Backup Contact:

N/A


Location Contact:

Mineola, New York 11501
United States

Julie DiGregorio, CCRP
Phone: 516-663-9614
Email: jdigregorio@winthrop.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.